Chong Kun Dang Pharmaceutical Corp. (KRX: 185750)
South Korea flag South Korea · Delayed Price · Currency is KRW
91,400
-900 (-0.98%)
Dec 19, 2024, 3:30 PM KST

Chong Kun Dang Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Net Income
189,039212,52180,95342,72091,63353,882
Upgrade
Depreciation & Amortization
37,03037,03033,59827,48223,78623,052
Upgrade
Loss (Gain) From Sale of Assets
-111.88-111.88-54.05-119.34-68.18-91.44
Upgrade
Asset Writedown & Restructuring Costs
199.79199.794,008--98.94172
Upgrade
Loss (Gain) From Sale of Investments
-1,465-1,4652,77298.87-517.38612.69
Upgrade
Loss (Gain) on Equity Investments
-798.36-798.36460.38603.47--
Upgrade
Provision & Write-off of Bad Debts
133.39133.39996.56-533.19800.02164.1
Upgrade
Other Operating Activities
15,14740,96922,30010,34532,92621,053
Upgrade
Change in Accounts Receivable
-20,947-20,947-45,316-18,267-10,26416,729
Upgrade
Change in Inventory
-5,980-5,980-54,466-53,771-46,240-48,845
Upgrade
Change in Accounts Payable
38,58438,58415,824-15,59842,35833,401
Upgrade
Change in Unearned Revenue
1.141.140.16--1,099540.11
Upgrade
Change in Other Net Operating Assets
-65,59018,0246,65819,942-28,892-23,379
Upgrade
Operating Cash Flow
185,241318,16067,73412,904104,32477,291
Upgrade
Operating Cash Flow Growth
-10.47%369.72%424.92%-87.63%34.98%81.32%
Upgrade
Capital Expenditures
-40,872-41,218-44,898-48,243-32,639-21,837
Upgrade
Sale of Property, Plant & Equipment
218.32451.58142.13142.4168.31334.66
Upgrade
Sale (Purchase) of Intangibles
-24,619-27,588-8,166-3,591-4,178-3,025
Upgrade
Investment in Securities
-106,785-102,998-12,806-39,332-27,440-15,252
Upgrade
Other Investing Activities
158.5739.75347.81213.96268.652.2
Upgrade
Investing Cash Flow
-171,899-171,313-65,380-90,809-63,921-39,727
Upgrade
Long-Term Debt Issued
-32,000-101,59683,22617,241
Upgrade
Long-Term Debt Repaid
--58,050-3,213-3,714-64,802-14,547
Upgrade
Net Debt Issued (Repaid)
-7,499-26,050-3,21397,88318,4242,694
Upgrade
Repurchase of Common Stock
-15,496-6,025-1,888-1,935-2,078-442.89
Upgrade
Dividends Paid
-13,331-11,609-11,239-10,808-9,277-8,839
Upgrade
Other Financing Activities
-26.71-16.53--0--
Upgrade
Financing Cash Flow
-36,353-43,700-16,34085,1397,069-6,588
Upgrade
Foreign Exchange Rate Adjustments
57.09-917.57-410.12920.1-734.87-1.89
Upgrade
Miscellaneous Cash Flow Adjustments
-0-----
Upgrade
Net Cash Flow
-22,954102,229-14,3968,15446,73730,974
Upgrade
Free Cash Flow
144,369276,94222,836-35,33971,68455,454
Upgrade
Free Cash Flow Growth
-12.02%1112.74%--29.27%167.74%
Upgrade
Free Cash Flow Margin
8.62%16.59%1.53%-2.63%5.50%5.14%
Upgrade
Free Cash Flow Per Share
11393.9421767.611781.20-2707.695452.184215.17
Upgrade
Cash Interest Paid
7,9228,6316,4443,7583,6372,942
Upgrade
Cash Income Tax Paid
35,24311,81215,56151,68818,26622,026
Upgrade
Levered Free Cash Flow
11,595169,732-1,365-33,05359,64447,377
Upgrade
Unlevered Free Cash Flow
16,985175,5262,914-30,53462,06449,346
Upgrade
Change in Net Working Capital
83,972-53,17846,31065,4062,364-4,545
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.